Catalyzing Capital, Innovation, and Impact to Advance Women's Health | Global Conference 2026
Why It Matters
The shift from awareness to coordinated investment and policy action promises to unlock research, new products and system-level reforms that can reduce costs and improve long-term health outcomes for women. Broad public-private momentum raises the prospect of faster commercialization and wider access to evidence-based care.
Summary
At the Global Conference panel, leaders from government, industry and philanthropy—including Dr. Jill Biden, California Surgeon General Dr. Diana Ramos, Merck’s Kalan Taylor Clark and entrepreneur Afton Vatcherie—marked the one-year anniversary of the Women’s Health Network and announced it now includes 170 organizations. Biden highlighted a $1 billion White House-era commitment to women’s health research and exposed longstanding gaps such as male-centric trials and neglect of menopause. Ramos described California’s cross-sector effort to halve maternal mortality by year-end and championed a life-course approach linking pregnancy complications to long-term cardiovascular and metabolic risks. Panelists said philanthropy, private industry and public policy are converging to catalyze funding, innovation and scaled solutions for women’s health today.
Comments
Want to join the conversation?
Loading comments...